Bacil Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Mar '26 Mar 6, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2020 - 2016
Market Capitalization	718	610	86	32	34	18	Upgrade
Market Cap Growth	283.03%	607.73%	166.97%	-4.36%	83.65%	89.09%	Upgrade
Enterprise Value	702	610	83	28	33	17	Upgrade
Last Close Price	50.00	42.49	14.63	5.48	5.73	3.12	Upgrade
PE Ratio	83.46	150.92	-	-	-	-	Upgrade
PS Ratio	130.98	-	-	-	-	-	Upgrade
PB Ratio	2.72	2.40	7.10	2.94	2.76	1.32	Upgrade
P/TBV Ratio	2.72	2.40	7.10	2.94	2.76	1.32	Upgrade
P/FCF Ratio	-	152.16	-	-	-	-	Upgrade
P/OCF Ratio	-	152.16	-	-	-	-	Upgrade
EV/Sales Ratio	128.07	-	-	-	-	-	Upgrade
EV/FCF Ratio	-	152.28	-	-	-	-	Upgrade
Debt / Equity Ratio	-	0.01	0.08	0.02	0.03	0.13	Upgrade
Debt / FCF Ratio	-	0.41	-	-	-	-	Upgrade
Net Debt / Equity Ratio	-0.06	-0.11	0.05	-0.18	-0.22	-0.04	Upgrade
Net Debt / EBITDA Ratio	-5.20	10.67	-0.30	1.12	1.76	0.39	Upgrade
Net Debt / FCF Ratio	-	-6.72	-19.64	1.35	0.07	0.16	Upgrade
Quick Ratio	-	16.92	0.37	7.87	6.49	0.09	Upgrade
Current Ratio	-	17.21	0.46	8.19	6.69	0.11	Upgrade
Return on Equity (ROE)	-	3.03%	-5.11%	-8.77%	-295.12%	-17.22%	Upgrade
Return on Assets (ROA)	-	-1.18%	-9.62%	-9.37%	-3.70%	-2.54%	Upgrade
Return on Invested Capital (ROIC)	0.94%	-2.09%	-17.40%	-19.41%	-13.92%	-12.52%	Upgrade
Return on Capital Employed (ROCE)	-	-1.00%	-15.60%	-16.30%	-13.00%	-12.00%	Upgrade
Earnings Yield	1.03%	0.66%	-0.69%	-3.16%	-114.37%	-13.02%	Upgrade
FCF Yield	-	0.66%	-0.03%	-4.57%	-118.79%	-21.66%	Upgrade
Buyback Yield / Dilution	-116.22%	-6.92%	1.47%	-1.71%	-0.99%	0.04%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.